Loading viewer...
investor_presentation
Format: PDF investor_presentation
Trimble Second Quarter 2018 Results Summary
Trimble Second Quarter 2018 Results Summary2Certain statements made inthis presentation and any subsequent Q&A period are forward -looking statements, within the meaning ofSection 21Eofthe
Securities Exchange Act of1934 ,asamended, and are made pursuant tothe safe harbor provisions ofthe Securities Litigation Reform Act of1995 .These
statements include expectations for future financial market and economic conditions, whether the positive trend infinancial results will continue through
2018 ,the impact ofacquisitions, including e-Builder and Viewpoint, the ability todeliver revenue, earnings per share and other financial projections that
Trimble has guided for the third quarter of2018 ,and fiscal 2018 ,including the expected tax rate, anticipated impact ofstock -based compensation expense,
amortization ofintangibles related toprevious acquisitions, anticipated acquisition costs, restructuring charges, the anticipated number ofdiluted shares
outstanding, our long -term growth targets and operating margins .These forward -looking statements are subject tochange, and actual results may materially
differ due tocertain risks and uncertainties .Trimble's expected tax rate and current expected income are based oncurrent tax law, including current
interpretations ofthe Tax Cuts and Jobs Act of2017 (”TCJA”), and may beaffected byevolving interpretations ofTCJA, the jurisdictions inwhich profits are
determined tobeearned and taxed, changes inthe estimates ofcredits, benefits and deductions, the resolution ofissues arising from tax audits with various
tax authorities, including payment ofinterest and penalties, and the ability torealize deferred tax assets .The company's results may beadversely affected if
the company isunable tomarket, manufacture and ship new products, obtain new customers, oreffectively integrate new acquisitions, including our recent
acquisition ofViewpoint .The company's results would also be negatively impacted by adverse geopolitical developments, weakening inthe macro
environment, foreign exchange fluctuations, critical part supply chain shortages, and the imposition ofbarriers tointernational trade .Any failure toachieve
predicted results could negatively impact the company's revenues, cash flow from operations, and other financial results .The company's financial results will
also depend onanumber ofother factors and risks detailed from time totime inreports filed with the SEC, including itsquarterly reports onForm 10-Qand
itsannual report onForm 10-K.Undue reliance should not beplaced onany forward -looking statement contained herein .These statements reflect the
Company’s position asofthe date ofthis presentation .The Company expressly disclaims any undertaking torelease publicly any updates orrevisions toany
statements toreflect any change inthe Company’s expectations orany change ofevents, conditions, orcircumstances onwhich any such statement isbased .
Preview truncated — download the full document for the complete content.
earnings
18 Pages
investor_presentation
21 Pages
Agora
Constellation Pharmaceuticals Investor Presentation — January 2020
investor_presentationinvestor_presentation
48 Pages
Constellation Pharmaceuticals